Nutriband Files U.S. Patent Application To Increase Protection For Its AVERSA Abuse Deterrent Transdermal Technology
This new patent application covers improved aversive formulations and coating application methods to enhance the abuse deterrent properties of Nutriband’s AVERSA™ transdermal technology and make it even more difficult
Share
Why It Matters
Nutriband is asking the government to protect a new way to stop drug misuse. This shows the company is working hard to make its medicine safer.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.